Lipid production
The present invention relates to at least one cell for producing at least one lipid with general formula II from at least one carbon substrate, wherein R 1 and R 2 independently of one another comprises identical or different organic radicals each with 5 to 13 carbon atoms, wherein the cell is a non-pathogenic cell that is genetically modified to increase the heterologous expression relative to the wild type cell of: an enzyme (E 2 ) capable of converting 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP or 3-(3-hydroxyalkanoyloxy)alkanoic acid (HAA) and NDP-glucose into β-D-glucopyranosyl-3-hydroxyalkanoyl-3-hydroxyalkanoate.
1. A microbial cell for producing at least one lipid with general formula II from at least one carbon substrate,
wherein R 1 and R 2 independently of one another comprise identical or different organic radicals each with 5 to 13 carbon atoms; and
wherein the cell is a non-pathogenic cell that is genetically modified to increase the heterologous expression relative to the wild type cell of an enzyme (E 2 ) capable of converting 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP and/or 3-(3-hydroxy-alkanoyloxy)alkanoic acid (HAA) in combination with NDP-glucose into β-D-glucopyranosyl-3-hydroxyalkanoyl-3-hydroxyalkanoate wherein the enzyme E 2 is a glycosyltransferase (EC 2.4) comprising SEQ ID NO: 4 or variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 4.
2. The microbial cell of claim 1 , wherein the R in the lipid with general formula II is a monounsaturated alkyl radical.
3. The microbial cell of claim 2 , wherein the alkyl radical is selected from the group consisting of nonenyl, undecenyl and tridecenyl.
4. The microbial cell of claim 1 , wherein the cell is further genetically modified to increase the heterologous expression relative to the wild type cell of an enzyme (E 1 ) capable of converting 3-hydroxyalkanoyl-CoA/ACP into 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP and further to 3-(3-hydroxy-alkanoyloxy)alkanoic acid (HAA).
5. The microbial cell of claim 3 , wherein the cell is further genetically modified to increase the heterologous expression relative to the wild type cell of an enzyme (E 1 ) capable of converting 3-hydroxyalkanoyl-CoA/ACP into 3-hydroxyalkanoyl-3-hydroxyalkanoyl-CoA/ACP and further to 3-(3-hydroxy-alkanoyloxy)alkanoic acid (HAA).
6. The microbial cell of claim 4 , wherein the enzyme E 1 is a 3-(3-hydroxy alkanoyloxy)alkanoic acid (HAA) synthase.
7. The microbial cell of claim 4 , wherein the enzyme E 1 comprises SEQ ID NO: 2 or variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 2.
8. The microbial cell of claim 6 , wherein the enzyme E 1 comprises SEQ ID NO: 2 or variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 2.
9. The microbial cell of claim 4 , wherein the enzyme E 1 comprises a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14 and variants thereof, wherein the variants comprise at least 90% sequence identity to SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12 and SEQ ID NO: 14 respectively.
10. The microbial cell of claim 6 , wherein the enzyme E 1 comprises a sequence selected from the group consisting of SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14 and variants thereof, wherein the variants comprise at least 90% sequence identity to SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12 and SEQ ID NO: 14 respectively.
11. The microbial cell of claim 1 , wherein the cell is genetically modified to increase the expression of: enzyme E 2 comprising SEQ ID NO: 4 or a variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 4; and —enzyme E 1 comprising SEQ ID NO: 2 or a variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 2.
12. The microbial cell of claim 10 , wherein the cell is genetically modified to increase the expression of: enzyme E 2 comprising SEQ ID NO: 4 or a variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 4; and —enzyme E 1 comprising SEQ ID NO: 2 or a variant thereof, wherein the variant comprises at least 90% sequence identity to SEQ ID NO: 2.
13. The microbial cell claim 1 , wherein the cell produces a further lipid with general formula I from the carbon substrate,
wherein R 1 and R 2 independently of one another comprise identical or different organic radicals each with 5 to 13 carbon atoms.
14. The microbial cell of claim 13 , wherein the R in the lipid with general formula I is a monounsaturated alkyl radical.
15. The microbial cell of claim 1 , wherein the carbon source is selected from the group consisting of glucose, dextrose, sucrose, polysaccharides, vegetal oils, animal fats, fatty acids, fatty acid esters, carbonaceous gases, alkanes, glycerol, acetate, ethanol and methanol.
16. The microbial cell of claim 14 , wherein the carbon source is selected from the group consisting of glucose, dextrose, sucrose, polysaccharides, vegetal oils, animal fats, fatty acids, fatty acid esters, carbonaceous gases, alkanes, glycerol, acetate, ethanol and methanol.
17. The microbial cell of claim 1 , wherein the cell is selected from the group consisting of Acinetobacter sp., Bacillus sp., Brevibacterium sp., Burkholderia sp., Chlorella sp., Clostridium sp., Corynebacterium sp., Cyanobakterien, Escherichia sp., Pseudomonas sp., Klebsiella sp., Salmonella sp., Rhizobium sp., Saccharomyces sp., Pichia sp., and Nostoc sp.
18. A method of producing at least one lipid with general formula II and/or general formula I:
wherein IV and R 2 independently of one another comprise identical or different organic radicals each with 5 to 13 carbon atoms; and
wherein the method comprises a step of contacting at least one microbial cell of claim 1 with at least one carbon source.